DK149188D0 - MATERIAL COMPOSITION AND PROCEDURES FOR IMMUNIZATION AGAINST VIRAL SOURCES FOR AIDS AND ARC - Google Patents

MATERIAL COMPOSITION AND PROCEDURES FOR IMMUNIZATION AGAINST VIRAL SOURCES FOR AIDS AND ARC

Info

Publication number
DK149188D0
DK149188D0 DK149188A DK149188A DK149188D0 DK 149188 D0 DK149188 D0 DK 149188D0 DK 149188 A DK149188 A DK 149188A DK 149188 A DK149188 A DK 149188A DK 149188 D0 DK149188 D0 DK 149188D0
Authority
DK
Denmark
Prior art keywords
aids
procedures
arc
material composition
against viral
Prior art date
Application number
DK149188A
Other languages
Danish (da)
Other versions
DK149188A (en
Inventor
Patrick Kanda
Ronald C Kennedy
Original Assignee
Southwest Found Biomed Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest Found Biomed Res filed Critical Southwest Found Biomed Res
Publication of DK149188D0 publication Critical patent/DK149188D0/en
Publication of DK149188A publication Critical patent/DK149188A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DK149188A 1986-07-21 1988-03-18 MATERIAL COMPOSITION AND PROCEDURES FOR IMMUNIZATION AGAINST VIRAL SOURCES FOR AIDS AND ARC DK149188A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88874286A 1986-07-21 1986-07-21
PCT/US1987/001733 WO1988000471A1 (en) 1986-07-21 1987-07-20 Composition of matter and method of immunizing against viral causative agents of aids and arc

Publications (2)

Publication Number Publication Date
DK149188D0 true DK149188D0 (en) 1988-03-18
DK149188A DK149188A (en) 1988-05-06

Family

ID=25393799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK149188A DK149188A (en) 1986-07-21 1988-03-18 MATERIAL COMPOSITION AND PROCEDURES FOR IMMUNIZATION AGAINST VIRAL SOURCES FOR AIDS AND ARC

Country Status (5)

Country Link
EP (1) EP0276279A4 (en)
JP (1) JPH01500432A (en)
AU (1) AU7786387A (en)
DK (1) DK149188A (en)
WO (1) WO1988000471A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US5126399A (en) * 1986-04-30 1992-06-30 Board Of Regents, The University Of Texas System Methods and compositions for the preparation and use of site-directed immunologic reagents
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0362909A3 (en) * 1988-08-26 1990-11-14 Akzo N.V. Synthetic polypeptides immunochemically reactive with hiv-antibodies
ZA896410B (en) * 1988-08-27 1990-05-30 Akzo Nv Synthetic peptides immunochemically reactive with hiv-antibodies
EP0436634A1 (en) * 1988-10-03 1991-07-17 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
IL94558A0 (en) * 1989-06-06 1991-03-10 Merck & Co Inc Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
EP0448095A1 (en) * 1990-03-21 1991-09-25 Wolf, Hans Joachim, Prof. Dr. Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
FR2677654B1 (en) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc COMPOUNDS WITH AN IMMUNOGENIC ANTI-CYTOKIN EFFECT, AN ANTIYTOSTATIC IMMUNOGENIC EFFECT OR AN ANTI-HIV INFECTION VACCINE EFFECT.
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
DE4417742A1 (en) 1994-05-20 1995-11-23 Bayer Ag Non-systemic control of parasites
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
EP1980617A1 (en) 1998-12-31 2008-10-15 Novartis Vaccines and Diagnostics, Inc. Improved expression of HIV polypeptides and production of virus-like particles
JP4776075B2 (en) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Modified HIVENV polypeptide
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US6659681B1 (en) 1999-02-10 2003-12-09 Traf Fix Devices, Inc. Laterally stable vertical panel system
EP2412242A3 (en) 2001-07-05 2012-06-13 Novartis Vaccines and Diagnostics, Inc. Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2002316578A1 (en) 2001-08-31 2003-03-18 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
CN106257728B (en) 2016-01-28 2018-01-12 中国科学院过程工程研究所 A kind of system and method for producing the high-purity V electrolyte of 3.5 valencys

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2702911B2 (en) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド Synthetic peptide, and method for detecting AIDS and pre-AIDS using the same

Also Published As

Publication number Publication date
EP0276279A1 (en) 1988-08-03
AU7786387A (en) 1988-02-10
JPH01500432A (en) 1989-02-16
WO1988000471A1 (en) 1988-01-28
EP0276279A4 (en) 1990-01-08
DK149188A (en) 1988-05-06

Similar Documents

Publication Publication Date Title
DK149188A (en) MATERIAL COMPOSITION AND PROCEDURES FOR IMMUNIZATION AGAINST VIRAL SOURCES FOR AIDS AND ARC
DK554685D0 (en) PURE-INHIBITING DIPEPTIDES AND PROCEDURES FOR PREPARING THEREOF
DK119385D0 (en) CERAMIC MATERIALS AND PROCEDURES FOR PRODUCING THEREOF
NO873695D0 (en) DENTAL IMPLANT OF THE SCREW TYPE AND PROCEDURE FOR USING THE SAME.
DK371489A (en) ENZYME ELECTRODES AND PROCEDURES FOR THE PRODUCTION OF SUCH ELECTRODES
NO860362L (en) CERAMIC COMPOSITION ARTICLES AND PROCEDURES FOR PRODUCING THEREOF.
DK210283A (en) PROCEDURE FOR THE PRODUCTION OF PLASMA, PLASMA PREPARATION AND VACCINE AGAINST HEPATITIS
NO880518L (en) DENTAL CEMENT MATERIAL.
AU1204388A (en) Opaque dental ceramic material
DK298789D0 (en) BOTTLE BOTTLE BOTTLE AND PROCEDURE FOR PREPARING THE SAME
DK164486D0 (en) MOLECULARALLY ORIENTED MATERIAL AND PROCEDURE FOR PREPARING THIS
DE3680392D1 (en) IMPLANT MATERIAL.
DK159288D0 (en) SACCHARID MIXTURE AND PROCEDURES FOR PREPARING THEREOF
IT8447804A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING RIFAMPICIN AND PROCEDURE FOR PREPARING IT
DK490088D0 (en) DEVICE FOR ENHANCING GAS MATERIALS
DK219588A (en) MATERIALS AND PROCEDURES FOR DIAGNOSTICATION OF CYSTIC FIBROSE
NO893892D0 (en) ANTIMICROBIOLOGICAL COMPOSITION AND PROCEDURE FOR USE.
DK165336C (en) CONCENTRATED SUBSTANCES AND THEIR PROCEDURES FOR THEIR PREPARATION
DK113187D0 (en) POROEST CRYSTALLINE OXID MATERIAL AND PROCEDURE FOR PREPARING THIS
DK159625C (en) SILO AND PROCEDURE FOR BURGING IT
DK152087D0 (en) ESTABLISHMENT AND PROCEDURE FOR SETTING THE DENTAL CHAIR
DK108483D0 (en) HAMMER MOLLE AND PROCEDURE FOR OPERATING THE SAME
DK674787D0 (en) HERBICID COMPOSITION AND PROCEDURE FOR USING THE SAME
NO892670L (en) GAS CLEANING MATERIALS AND PROCEDURE FOR THEIR PREPARATION.
DE3689822T2 (en) Asymmetrically accelerated vibrator for material handling.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment